ChAdV63.HIVconsv
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ChAdV63.HIVconsv, covering 2024-05-07 to 2024-05-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals [Phase 1]